by admin | Jan 9, 2025 | News
Leyden Labs, based at Leiden Bio Science Park, has raised $70 million to develop a new way to fight respiratory viruses. Their intranasal antibody technology targets viruses like influenza and coronaviruses at the point of entry—the nasal mucosa—offering a practical,...
by Carlos LBSP | Jan 7, 2025 | News
Axite has secured €250,000 in Takeoff 2 early-stage funding, a significant step forward in their journey of innovation and growth. Meanwhile, 1NA has been honored with the prestigious 2025 CES Innovation Award, recognizing their outstanding contributions to technology...
by Kenjiro Lolling | Dec 20, 2024 | News
How does collaboration work at different scales: provincial (e.g., EBZ and the province), regional (e.g., Holland Rijnland), and cluster-specific (e.g., Leiden Bio Science Park)? These interconnected levels play a vital role in building a stronger South Holland. In...
by Kenjiro Lolling | Dec 19, 2024 | News
Leiden Bio Science Park (LBSP) had the honor of hosting a Swiss delegation, organized by Roche, Novartis, Rijksdienst voor Ondernemend Nederland, Health Holland, and other partners. The visit showcased the innovative collaborations and research driving advancements in...
by Kenjiro Lolling | Dec 13, 2024 | News
The labor market in the Netherlands is under significant strain, and healthcare is one of the sectors most affected. This impacts all of us. Ahead of an upcoming Commission debate on Labor Market Policy in Healthcare in our national parliament (Tweede Kamer) on...
by Kenjiro Lolling | Dec 10, 2024 | News
New Approach: Recognizing International Players in Local R&D For the 2024 edition, the criteria have shifted to include R&D activities conducted in the Netherlands, regardless of a company’s headquarters location. This acknowledges the contributions of global...